Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine.
Brichacek B, Swindells S, Janoff EN, Pirruccello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis. 1996 Dec; 174(6):1191-9.